| Dec 20, 2013
| 2:38 AM
Dec 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets
| Dec 19, 2013
| 1:03 PM
Dec 19 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Thursday:
** Belgian financial group KBC said it would sell Antwerp
Diamond Bank to a Chinese investor, the final unit it agreed to
sell for approval...
| Dec 16, 2013
| 7:30 AM
Dec 16 (Reuters) - Agenus Inc said more than 90
percent of patients treated with its experimental brain cancer
vaccine were alive six months after undergoing surgery to remove
Agenus shares soared as much as 32 percent in early trading....
| Dec 3, 2013
| 11:54 AM
By Sharon Begley
Dec 3 (Reuters) - A former hedge-fund analyst who argued
that Dendreon Corp's therapeutic vaccine for prostate
cancer may hasten the death of patients has reached a settlement
with U.S. securities regulators over failure to disclose...
| Apr 29, 2010
| 5:15 PM
The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer therapy, adding...